The pharmaceutical industry export market share in Denmark was 2.95% in 2023. Forecasted data show a slight but steady increase from 2.96% in 2024 to 2.98% by 2028. Year-on-year variation is minimal, under 1%, indicating stable growth. Over the last two years, the market share grew by a modest rate of about 0.34%, and the Compound Annual Growth Rate (CAGR) for the next five years is projected to be similarly stable at approximately 0.17%.
Future trends to watch for include potential regulatory changes in the European Union, advancements in pharmaceutical technology, and shifts in global healthcare demands which may influence Denmark's export market share. Additionally, strategic trade agreements and investment in biotechnology could bolster growth.
